To explore the underlying molecular mechanism of YBX1 interaction with G3BP1 in RCC progression, we investigated the effects of G3BP1 on the oncogenic signaling pathways that can be affected by YBX1 silencing. The gene discussed is G3BP1; the disease is renal cell carcinoma.